BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8213473)

  • 1. Use of calcium channel antagonists for cardiovascular disease.
    Yedinak KC
    Am Pharm; 1993 Aug; NS33(8):49-64; quiz 64-6. PubMed ID: 8213473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):625-56. PubMed ID: 3154329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension.
    Walton T; Symes LR
    Clin Pharm; 1993 Apr; 12(4):261-75. PubMed ID: 8458178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.
    Katz AM; Leach NM
    J Clin Pharmacol; 1987 Nov; 27(11):825-34. PubMed ID: 3323259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities and differences between calcium antagonists: pharmacological aspects.
    van Zwieten PA; Pfaffendorf M
    J Hypertens Suppl; 1993 Mar; 11(1):S3-11. PubMed ID: 8483019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists].
    Rameis H
    Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel antagonists. What do the second-generation agents have to offer?
    Salerno SM; Zugibe FT
    Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-channel blockers and the elderly.
    Ryan C
    Compr Ther; 1990 Jun; 16(6):51-4. PubMed ID: 2373003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
    Apostolakos MJ; Varon ME
    New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.
    Little WC; Cheng CP; Elvelin L; Nordlander M
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):657-63. PubMed ID: 8573548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists.
    Vetrovec GW
    Am J Cardiol; 1994 Jan; 73(3):34A-38A. PubMed ID: 8310974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):461-91. PubMed ID: 3154677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
    Opie LH
    Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.
    Freedman DD; Waters DD
    Drugs; 1987 Nov; 34(5):578-98. PubMed ID: 3319491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel antagonists. Part V: Second-generation agents.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Jul; 2(2):191-203. PubMed ID: 3154705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of calcium antagonists].
    Jounela A
    Duodecim; 1986; 102(22):1717-24. PubMed ID: 3803260
    [No Abstract]   [Full Text] [Related]  

  • 18. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition.
    Bühler FR
    J Hypertens Suppl; 1997 Dec; 15(5):S3-7. PubMed ID: 9481610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists and cardiovascular disorders.
    Krikler DM
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):513-8. PubMed ID: 6241445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.